Emerging evidence on the pathobiology of mucositis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Supportive Care in Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00520-013-1810-yPMID 23604521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea

  2012cited by this paper
• New frontiers in mucositis.

  2012cited by this paper
• Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

  2012cited by this paper
• Tumor control versus adverse events with targeted anticancer therapies

  2012cited by this paper
• Genome-wide association studies and prediction of normal tissue toxicity.

  2012cited by this paper
• Methotrexate Modulates Tight Junctions Through NF-&kgr;B, MEK, and JNK Pathways

  2012cited by this paper
• Lymphocyte subsets, granulocyte-colony-stimulating factor responsiveness and post-stem cell transplantation infections: mucositis is the underestimated confounder?

  2012cited by this paper
• Effects of intensity-modulated radiotherapy on human oral microflora.

  2011cited by this paper
• Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation

  2011cited by this paper
• Role of AMP-18 in oral mucositis.

  2011cited by this paper
• Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis.

  2011cited by this paper
• Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats

  2011cited by this paper
• Irinotecan‐induced alterations in intestinal cell kinetics and extracellular matrix component expression in the dark agouti rat

  2011cited by this paper
• The correlation between the severity of radiotherapy-induced glossitis and endothelial cell injury in local tissues in a rat model.

  2011cited by this paper
• Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer

  2011cited by this paper
• Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.

  2011cited by this paper
• The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis

  2010cited by this paper
• Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study.

  2010cited by this paper
• Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis

  2010cited by this paper
• Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat

  2010cited by this paper
• Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma.

  2010cited by this paper
• Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats

  2010cited by this paper
• A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation.

  2010cited by this paper
• Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.

  2009cited by this paper
• Irinotecan‐induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile

  2009cited by this paper
• Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies

  2009cited by this paper
• Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.

  2009cited by this paper
• Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis

  2009cited by this paper
• Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.

  2009cited by this paper
• Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients

  2009cited by this paper
• Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model.

  2009cited by this paper
• Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.

  2009cited by this paper
• Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies.

  2009cited by this paper
• Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients

  2009cited by this paper
• Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?

  2008cited by this paper
• Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis

  2008cited by this paper
• Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs.

  2008cited by this paper
• Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.

  2008cited by this paper
• Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability1

  2008cited by this paper
• Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats

  2008cited by this paper
• Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy

  2008cited by this paper
• Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer

  2008cited by this paper
• Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.

  2008cited by this paper
• Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report

  2008cited by this paper
• Updated clinical practice guidelines for the prevention and treatment of mucositis

  2007cited by this paper
• Intestinal Toxicity Induced by 5-Fluorouracil in Pigs: A New Preclinical Model

  2007cited by this paper
• Mucosal injury from targeted anti-cancer therapy

  2007cited by this paper
• Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.

  2007cited by this paper
• Chemotherapy-Induced Diarrhea Is Associated with Changes in the Luminal Environment in the DA Rat

  2007cited by this paper
• The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

  2007cited by this paper
• Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.

  2007cited by this paper
• Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy.

  2007cited by this paper
• Establishment of a Single-Dose Irinotecan Model of Gastrointestinal Mucositis

  2007cited by this paper
• Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis

  2006cited by this paper
• Contributions of mucosal immune cells to methotrexate-induced mucositis.

  2006cited by this paper
• Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis

  2006cited by this paper
• Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

  2006cited by this paper
• New thoughts on the pathobiology of regimen-related mucosal injury

  2006cited by this paper
• Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters.

  2005cited by this paper
• Cytotoxic chemotherapy upregulates pro‐apoptotic Bax and Bak in the small intestine of rats and humans

  2005cited by this paper
• Intestinal Permeability in the Assessment of Intestinal Toxicity of Cytotoxic Agents

  2005cited by this paper
• Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes.

  2005cited by this paper
• Monitoring myeloablative therapy‐induced small bowel toxicity by serum citrulline concentration

  2005cited by this paper
• Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat

  2005cited by this paper
• Efficacy and Safety of Trastuzumab as a Single Agent in Heavily Pretreated Patients with Her-2/NEU-Overexpressing Metastatic Breast Cancer

  2004cited by this paper
• The pathobiology of mucositis.

  2004cited by this paper
• A biological approach to mucositis.

  2004cited by this paper
• Oral RDP58 Allows CPT-11 Dose Intensification for Enhanced Tumor Response by Decreasing Gastrointestinal Toxicity

  2004cited by this paper
• Intestinal Barrier Function and Secretion in Methotrexate-Induced Rat Intestinal Mucositis

  2004cited by this paper
• TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.

  2004cited by this paper
• Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib.

  2004cited by this paper
• The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis.

  2004cited by this paper
• Perspectives on cancer therapy‐induced mucosal injury

  2004cited by this paper
• Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.

  2003cited by this paper
• The burdens of cancer therapy

  2003cited by this paper
• Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders.

  2003cited by this paper
• Proinflammatory Cytokines Cause No·-Dependent and -Independent Changes in Expression and Localization of Tight Junction Proteins in Intestinal Epithelial Cells

  2003cited by this paper
• A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

  2002cited by this paper
• Effect of Interleukin-11 on Ameliorating Intestinal Damage After Methotrexate Treatment of Breast Cancer in Rats

  2002cited by this paper
• The gene expression sequence of radiated mucosa in an animal mucositis model

  2002cited by this paper
• Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.

  2002cited by this paper
• The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy.

  2002cited by this paper
• Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice

  2001cited by this paper
• Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.

  2001cited by this paper
• Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans

  2000cited by this paper
• Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters.

  2000cited by this paper
• Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

  2000cited by this paper
• The impact of mucositis on α‐hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies

  1998cited by this paper
• Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting.

  1998cited by this paper
• Inflammatory bowel disease: etiology and pathogenesis.

  1998cited by this paper
• Apoptosis and the dilemma of cancer chemotherapy.

  1997cited by this paper
• Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

  1994cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• The extracellular matrix as a cell survival factor.

  1993cited by this paper
• Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy.

  1992cited by this paper
• The role of oral microorganisms in cancer therapy.

  1992cited by this paper
• An animal model for mucositis induced by cancer chemotherapy.

  1990cited by this paper
• Opportunistic gram-negative bacillary infections in leukemia. Oral manifestations during myelosuppression.

  1974cited by this paper
• The nature and control of infections in patients with acute leukemia.

  1965cited by this paper

• Huangqi Baihe Granules alleviate chemotherapy-induced intestinal mucositis in Drosophila and mice.

  2026cites this paper
• Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment

  2025cites this paper
• Lapatinib modulates Caco-2 intestinal monolayer permeability through ErbB1 inhibition-mediated tight junction alteration

  2025cites this paper
• A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy

  2025cites this paper
• Mitigation of Methotrexate-Induced Intestinal Mucositis in Male Wistar Rats by Gallic Acid: The Role of HGF and C-Met Genes

  2025cites this paper
• The Effect of Rabdosia rubescens on Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients: A Phase II Clinical Study

  2025cites this paper
• Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial.

  2025cites this paper
• Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study

  2024cites this paper
• Gold nanoparticles as innovative therapeutics for oral mucositis: A review of current evidence

  2024cites this paper
• Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework

  2024cites this paper
• Association of oral mucositis induced by anthracycline-cyclophosphamide and subsequent docetaxel treatment for perioperative breast cancer

  2024cites this paper
• Application of In Situ Mucoadhesive Hydrogel with Anti-Inflammatory and Pro-Repairing Dual Properties for the Treatment of Chemotherapy-Induced Oral Mucositis.

  2024cites this paper
• Efficacy of Episil® in patients with hematologic malignancies: a comparative study

  2024cites this paper
• Radiotherapy-induced severe oral mucositis: pharmacotherapies in recent and current clinical trials

  2023cites this paper
• Secondary lesions of the mucous membrane of the oral cavity as a side effect of complex anticancer treatment: a literature review

  2023cites this paper
• Efficacy of Low-Level Laser Therapy for Oral Mucositis in Hematologic Patients Undergoing Transplantation: A Single-Arm Prospective Study

  2023cites this paper
• Assessment of Oxidative Stress-Induced Oral Epithelial Toxicity

  2023cites this paper
• High molecular weight hyaluronic acid drastically reduces chemotherapy-induced mucositis and apoptotic cell death

  2023cites this paper
• Rodent models for anticancer toxicity studies: contributions to drug development and future perspectives.

  2023cites this paper
• Case–control study analyzing the relationship between oral microcirculation and oral mucositis and pain in patients under antineoplastic therapy

  2023cites this paper
• Lycium barbarum polysaccharide-glycoprotein ameliorates ionizing radiation-induced epithelial injury by regulating oxidative stress and ferroptosis via the Nrf2 pathway

  2023cites this paper
• Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation.

  2023cites this paper
• Identification of potential molecular mechanisms and candidate drugs for radiotherapy- and chemotherapy-induced mucositis

  2023cites this paper
• Characterization of a novel dual murine model of chemotherapy-induced oral and intestinal mucositis

  2023cites this paper
• Probiotics for the Management of Oral Mucositis: An Interpretive Review of Current Evidence

  2022cites this paper
• PET/CT imaging detects intestinal inflammation in a mouse model of doxorubicin-induced mucositis

  2022cites this paper
• Preventive Effect of Probiotics on Oral Mucositis Induced by Cancer Treatment: A Systematic Review and Meta-Analysis

  2022cites this paper
• Protective Effect of Plumeria pudica Latex Proteins on Intestinal Mucositis Induced by 5-Fluorouracil.

  2022cites this paper
• Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment

  2022cites this paper
• Dual roles of ANGPTL4 in multiple inflammatory responses in stomatitis mice

  2022cites this paper
• Role of ErbB1 in the Underlying Mechanism of Lapatinib-Induced Diarrhoea: A Review

  2022cites this paper
• Effectiveness of Cryotherapy on Cancer Therapy–Induced Oral Mucositis

  2022cites this paper
• Microbial Analysis of Obturators During Maxillofacial Prosthodontic Treatment Over an 8-Year Period

  2022cites this paper
• Low-level Laser Therapy in the Management of Oral Mucositis Induced by Radiotherapy: A Randomized Double-blind Clinical Trial.

  2022cites this paper
• Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways

  2022cites this paper
• The Intestinal Redox System and Its Significance in Chemotherapy-Induced Intestinal Mucositis

  2022cites this paper
• Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis

  2022cites this paper
• Evaluation of the antiapoptotic and anti-inflammatory properties of chitosan in methotrexate-induced oral mucositis in rats

  2022cites this paper
• Analgesic effects of indomethacin spray on drug‐induced oral mucositis pain in patients with cancer: A single‐arm cross‐sectional study

  2021cites this paper
• Effect of Ozonated Water on Oral Mucositis and Pain Induced by Head and Neck Radiotherapy: A Cross-sectional Study

  2021cites this paper
• Emerging approaches of wound healing in experimental models of high-grade oral mucositis induced by anticancer therapy

  2021cites this paper
• Oral Mucositis in Cancer and Potential Use of Omega-3 Free Fatty Acids in Its Management: A Review

  2021cites this paper
• Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?

  2021cites this paper
• Risk factors for oral mucositis during chemotherapy treatment for solid tumors: a retrospective STROBE-guided study

  2021cites this paper
• Therapeutic intervention using a Smad7-based Tat protein to treat radiation- induced oral mucositis.

  2021cites this paper
• The Impact of Probiotics on Intestinal Mucositis during Chemotherapy for Colorectal Cancer: A Comprehensive Review of Animal Studies

  2021cites this paper
• β-Patchoulene Ameliorates Water Transport and the Mucus Barrier in 5-Fluorouracil-Induced Intestinal Mucositis Rats via the cAMP/PKA/CREB Signaling Pathway

  2021cites this paper
• Assessing the topical application efficiency of two biological agents in managing chemotherapy-induced oral mucositis in children: A randomized clinical trial.

  2021cites this paper
• Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies

  2021cites this paper
• Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy

  2021cites this paper
• FIBCD1 ameliorates weight loss in chemotherapy-induced murine mucositis

  2020cites this paper
• Evaluation of Efficacy of Low-Level Laser Therapy.

  2020cites this paper
• Oral mucositis in patients with oncological pathology of the oropharyngeal region: review

  2020cites this paper
• Transplant-Related Non-pain Issues: Prevention, Intervention, and Limitations

  2020cites this paper
• An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis

  2020cites this paper
• Herpesviruses in the oral cavity of patients subjected to allogeneic hematopoietic stem cell transplantation and its relationship with oral mucositis

  2020cites this paper
• Grape Seed and Physalis Extracts as Anti- Inflammatory Agents in Cetuximab Induced Tongue Mucositis in Rats

  2020cites this paper
• Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial.

  2020cites this paper
• New therapeutic strategies for combatting gastrointestinal toxicity.

  2020influential citation
• The role of NLRP3 inflammasome activation in radiation damage.

  2019cites this paper
• Modulatory effect of a new benzopyran derivative via COX-2 blocking and down regulation of NF-κB against γ-radiation induced- intestinal inflammation.

  2019cites this paper
• Selective MMP Inhibition, Using AZD3342, to Reduce Gastrointestinal Toxicity and Enhance Chemoefficacy in a Rat Model

  2019cites this paper
• Reduced Plasma Amino Acid Levels During Allogeneic Hematopoietic Stem Cell Transplantation Are Associated with Systemic Inflammation and Treatment-Related Complications.

  2019cites this paper
• Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model

  2019cites this paper
• Prophylaxis and Management of Skin Toxicities

  2019cites this paper
• Animal models of mucositis: critical tools for advancing pathobiological understanding and identifying therapeutic targets

  2019cites this paper
• Protective Effect of Cashew Gum (Anacardium occidentale L.) on 5-Fluorouracil-Induced Intestinal Mucositis

  2019cites this paper
• Highlight article: Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity

  2019cites this paper
• Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.

  2019cites this paper
• The pathogenesis of mucositis: updated perspectives and emerging targets.

  2019cites this paper
• Comparative Study of the Effect of Licorice Root Extract Mouthwash and Combined Mouthwash on the Incidence and Severity of Chemotherapy-Induced Mucositis Symptoms in Colon Cancer Patients Admitted to Intensive Care Units

  2019cites this paper
• Zinc deficits, mucositis, and mucosal macrophage perturbation: is there a relationship?

  2019cites this paper
• Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.

  2019cites this paper
• The The Effectiveness Of Oral Cryotherapy To Reduce Oral Mucositis Among Cancer Patients Undergoing Chemotherapy: A Literature Review

  2019cites this paper
• Oral Mucosal Status of Children with Cancer Undergoing Treatment at a Tertiary Health Care Facility in Lucknow , India

  2019cites this paper
• Oral Mucosal Injury Caused by Targeted Cancer Therapies.

  2019cites this paper
• Effects of Early Nutritional Intervention on Oral Mucositis in Patients with Radiotherapy for Head and Neck Cancer.

  2019cites this paper
• Using Bee Products for the Prevention and Treatment of Oral Mucositis Induced by Cancer Treatment

  2019cites this paper
• Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer

  2019cites this paper
• Photobiomodulation effects on head and neck squamous cell carcinoma (HNSCC) in an orthotopic animal model

  2019cites this paper
• Pharmacological modulation of radiation-induced oral mucosal complications.

  2018cites this paper
• The Effect of Chlorhexidine Mouthwash on Chemoradiotherapy Induced Mucositis in Patients of Head and Neck Cancer

  2018cites this paper
• Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model

  2018cites this paper
• Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP

  2018cites this paper
• Trophic factors in the treatment and prevention of alimentary tract mucositis

  2018cites this paper
• Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis

  2018cites this paper
• Variation of Energy in Photobiomodulation for the Control of Radiotherapy-Induced Oral Mucositis: A Clinical Study in Head and Neck Cancer Patients

  2018cites this paper
• Chemopreventive effects of FITOPROT against 5‐fluorouracil‐induced toxicity in HaCaT cells

  2018cites this paper
• TNF as marker of oral candidiasis, HSV infection, and mucositis onset during chemotherapy in leukemia patients.

  2017cites this paper
• Estudo epidemiológico e nível de conhecimento de pacientes oncológicos acerca da mucosite oral e laserterapia/Epidemiological study and level of knowledge of oncologic patients about oral mucositis and lasertherapy

  2017cites this paper
• A Comprehensive Look at Oromaxillofacial and Laryngopharyngeal Cancers

  2017cites this paper
• Early and Acute Complications and the Principles of HSCT Nursing Care

  2017cites this paper
• CE: Oral Care for Head and Neck Cancer Symptom Management

  2017cites this paper
• Intestinal toxicity evaluation of long‐circulating and pH‐sensitive liposomes loaded with cisplatin

  2017cites this paper
• Melatonin protects rats from radiotherapy-induced small intestine toxicity

  2017cites this paper
• New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury

  2017cites this paper
• Ecological Therapeutic Opportunities for Oral Diseases

  2017cites this paper
• Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation

  2017cites this paper
• Cannabidiol: an alternative therapeutic agent for oral mucositis?

  2017cites this paper
• Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms

  2016cites this paper